Merck discontinues development of 2 experimental cancer drugs after trial failures - Reuters.com

Reuters | Dec. 16, 2024, 5:14 p.m. | Original
Merck discontinues development of 2 experimental cancer drugs after trial failures Reuters.com
Explainer: How would a U.S. bitcoin strategic reserve work? - Reuters.com Nucor forecasts lower-than-expected fourth-quarter profit - Reuters.com